Federal health officials are urging seniors to avoid the Ixchiq vaccine for chikungunya due to serious health risks, including deaths and severe side effects. The CDC is currently investigating these alarming reports.
U.S. health officials have advised patients to pause the Ixchiq vaccine after reports of serious adverse events. Investigations are ongoing as the FDA reassesses its safety for older adults.
